XML 162 R132.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-Based Compensation - Non-Qualified Stock Options (Details) - NQSOs - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Stock-Based Compensation      
Award vesting period 3 years    
Shares granted during the period 0 0 0
Maximum contractual term for outstanding options (in years) 10 years    
NQSO activity and changes      
Outstanding at the beginning of the period (in shares) 1,522,919    
Forfeited (in shares) (50,001)    
Exercised (in shares) (187,060) 0  
Outstanding at the end of the period (in shares) 1,285,858.000000 1,522,919  
Exercisable at the end of the period (in shares) 1,285,858    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]      
Outstanding (in usd per share) $ 25.03    
Forfeited (in usd per share) 29.35    
Exercised (in usd per share) 20.71    
Outstanding (in usd per share) 25.49 $ 25.03  
Exercisable (in usd per share) $ 25.49    
Weighted Average Remaining Contractual Term, Outstanding 3 years 3 years  
Weighted Average Remaining Contractual Term, Exercisable 3 years    
Aggregate Intrinsic Value, Outstanding $ 6 $ 0  
Aggregate Intrinsic Value, Exercisable 6    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures      
Total intrinsic value of options exercised 1 0 $ 2
Cash received from options exercised $ 4 $ 0 $ 9
GenOn Employees      
NQSO activity and changes      
Exercised (in shares) (51,207,000,000)    
Outstanding at the end of the period (in shares) 51,207    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]      
Shares vested (in shares) 51,207,000,000